When Is Surgical Intervention Indicated in Alpha-1-Antitrypsin Deficiency?
Alpha-1-antitrypsin deficiency (AATD) is a hereditary condition that can lead to progressive organ damage. In a subset of patients, disease severity reaches a point where surgical options become relevant clinical considerations.
Clinical scenario: Patients with advanced or end-stage disease from AATD in whom specific surgical procedures may be appropriate — subject to careful patient selection and centre expertise.
Treatment Approach
The protocol addresses surgical lung-based interventions for appropriately selected patients, with separate considerations for those with severe or terminal disease. Patient eligibility criteria, procedural sequencing, and the role of specialist centres are covered in the full regimen.
Full selection criteria and clinical algorithm available in the complete protocol.
References
- In very well-selected cases, lung volume reduction surgery has produced positive results (functional improvement and better quality of life).
- At major centers worldwide, AATD is one of the main indications for lung transplantation.
- Lung and liver transplantation are reserved for severe and terminal cases of AATD.
View source ↗